HRMY

42.25

0.93% 0.39

Dopo l'orario di chiusura: 42.25

Harmony Biosciences Holdings Inc (HRMY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRMY Giù? Forum Previsione

Precedente Chiudi:

$41.86

Aprire:

$41.5

Volume 24 ore:

659.59K

Relative Volume:

0.81

Capitalizzazione di mercato:

$2.46B

Reddito:

$899.11M

Utile/perdita netta:

$145.62M

Rapporto P/E:

17.02

EPS:

2.4829

Flusso di cassa netto:

$322.54M

1 W Prestazione:

+7.75%

1M Prestazione:

+8.95%

6M Prestazione:

+48.04%

1 anno Prestazione:

+16.39%

Intervallo 1D:

$41.36

$42.34

Intervallo di 1 settimana:

$38.97

$43.49

Portata 52W:

$25.52

$43.49

Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile

Nome

Harmony Biosciences Holdings Inc

Settore

Healthcare (1074)

Industria

Biotechnology (600)

Telefono

(484) 539-9800

Indirizzo

630 W GERMANTOWN PIKE, PLYMOUTH MEETING

Dipendente

293

Cinguettio

Prossima data di guadagno

2026-08-04

Ultimi documenti SEC

HRMY's Discussions on Twitter

Compare HRMY vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HRMY Harmony Biosciences Holdings Inc	42.25	2.22B	899.11M	145.62M	322.54M	2.4829
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-23	Downgrade	Deutsche Bank	Buy → Hold
2026-02-23	Downgrade	Truist	Buy → Hold
2026-02-11	Ripresa	UBS	Neutral
2025-07-21	Iniziato	Truist	Buy
2025-07-10	Ripresa	Goldman	Neutral
2025-06-02	Ripresa	Oppenheimer	Outperform
2025-02-11	Iniziato	Deutsche Bank	Buy
2024-12-17	Iniziato	H.C. Wainwright	Buy
2024-10-10	Ripresa	Raymond James	Outperform
2024-09-10	Iniziato	UBS	Buy
2024-06-21	Iniziato	Citigroup	Buy
2024-01-02	Downgrade	BofA Securities	Neutral → Underperform
2023-09-25	Downgrade	Goldman	Neutral → Sell
2023-09-07	Iniziato	Berenberg	Buy
2023-04-20	Iniziato	BofA Securities	Neutral
2022-10-14	Aggiornamento	Janney	Neutral → Buy
2022-10-14	Aggiornamento	Jefferies	Hold → Buy
2022-08-03	Downgrade	Jefferies	Buy → Hold
2022-07-13	Downgrade	Goldman	Buy → Neutral
2022-07-07	Iniziato	Mizuho	Buy
2022-04-14	Iniziato	Cantor Fitzgerald	Overweight
2021-12-01	Iniziato	Oppenheimer	Outperform
2021-11-04	Iniziato	Raymond James	Outperform
2021-09-23	Iniziato	Needham	Buy
2021-03-29	Aggiornamento	Goldman	Neutral → Buy
2020-09-14	Iniziato	Goldman	Neutral
2020-09-14	Iniziato	Jefferies	Buy
2020-09-14	Iniziato	Piper Sandler	Overweight

Mostra tutto

Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie

Aug 21, 2026

Virtus Advisers LLC Makes New Investment in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Aug 21, 2026

Aug 20, 2026

Tieton Capital Management LLC Takes Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Aug 20, 2026

Denali Advisors LLC Purchases 29,700 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Aug 20, 2026

Stephen M. Mollichella Net Worth (2026) - GuruFocus

Aug 20, 2026

Aurora Investment Counsel Invests $2.37 Million in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Aug 20, 2026

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Aug 20, 2026

Aug 17, 2026

Did Strong Q2 Earnings and Completed Buybacks Just Shift Harmony Biosciences' (HRMY) Investment Narrative? - simplywall.st

Aug 17, 2026

Chase Investment Counsel Corp Takes $1.82 Million Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Aug 17, 2026

Aug 16, 2026

Harmony Biosciences (NASDAQ:HRMY) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat

Aug 16, 2026

Aug 15, 2026

HRMY Stock On Track For Best Intraday Gains In 18 Months — What Did Mizuho Analysts Say? - stocktwits.com

Aug 15, 2026

Aug 14, 2026

Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline - MarketBeat

Aug 14, 2026

Aug 13, 2026

HRMY: Record WAKIX sales drive CNS pipeline progress, with BP-205 and new pitolisant forms advancing - TradingView

Aug 13, 2026

Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Corbus Pharmaceuticals (CRBP) - The Globe and Mail

Aug 13, 2026

Zacks Research Downgrades Harmony Biosciences (NASDAQ:HRMY) to Hold - MarketBeat

Aug 13, 2026

Aug 12, 2026

Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo Finance

Aug 12, 2026

Harmony Sets Investor Appearance as CNS Strategy Advances - MyChesCo

Aug 12, 2026

Hennion & Walsh Asset Management Inc. Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat

Aug 12, 2026

Aug 11, 2026

Harmony Biosciences Holdings (HRMY) Stock Analysis: Exploring an 18% Potential Upside with Strong Revenue Growth - DirectorsTalk Interviews

Aug 11, 2026